Tuesday, July 26 11:30 a.m. – 12:30 p.m. Exhibit Hall Theater 1 Supported by Roche
This panel discussion will evaluate the close link between type II diabetes and heart failure and how we can improve both diagnosis and treatment for patients. The session will highlight the most important biomarker updates from the recently published HFSA Heart Failure Guidelines as well as the ADA Consensus Report on Type II Diabetes and Heart Failure in an insightful multidisciplinary discussion offering perspectives from respected experts in the field. The discussion will dive deeper into early identification of patients at risk, multimarker approaches, frequency of monitoring, and innovative diagnostic solutions.
Alexander Fohl, PharmD Scientific Liaison, Core Lab and Point of Care Roche
Ambarish Pandey, MD, MSCS, FAHA
Assistant Professor of Internal Medicine Medical Director, Heart Failure with Preserved Ejection Fraction Program Associate Program Director for Residency Training Department of Internal Medicine, Division of Cardiology UT Southwestern Medical Center, Dallas, Texas
Ibrahim A. Hashim, MSc, PhD, FIBMS, CSc, DABCC, FAACC Professor, Arthur J. Gill Professorship in Pathology Chief of Clinical Pathology, Clinical Chemistry Director, University of Texas Southwestern Medical Center, Parkland Memorial Hospital, Dallas, Texas
David C. Klonoff, M.D., FACP, FRCP (Edin), Fellow AIMBE Medical Director, Diabetes Research Institute Mills-Peninsula Medical Center, San Mateo Clinical Professor of Medicine, U.C. San Francisco Editor-in-Chief, Journal of Diabetes Science and Technology
Be the first to get all the latest news.